“…To collect and handle ovarian follicles and OCCs, 25 mM HEPES-buffered medium 199 (HEPES-199; Nissui Pharmaceutical, Tokyo, Japan) containing 0.1% (w/v) polyvinyl alcohol (PVA), 0.85 mg/ml sodium bicarbonate, and 0.08 mg/ml kanamycin sulfate was used. The basic growth medium was Minimum Essential Medium α (GIBCO Invitrogen, Paisley, UK) supplemented with 2.2 mg/ml sodium bicarbonate, 0.08 mg/ml kanamycin sulfate, 2% (w/v) polyvinylpyrrolidone (molecular weight 360,000), 55 µg/ml L-cysteine, 0.05 µM dexamethasone, 4.0 mM hypoxanthine, 50 µg/ml ascorbic acid 2-glucoside (Hayashibara, Okayama, Japan), 10 µM 17β-estradiol, 0.01 IU/ml Gonalef 75 (recombinant human follicle-stimulating hormone; Merck Biopharma Japan, Tokyo, Japan), and 5% (v/v) fetal bovine serum (ICN Biomedicals, Costa Mesa, CA, USA) as reported previously [ 24 ].…”